Medication possession ratio: implications of using fixed and variable observation periods in assessing adherence with disease-modifying drugs in patients with multiple sclerosis
Open Access
- 1 June 2013
- journal article
- research article
- Published by Informa UK Limited in Patient Preference and Adherence
- Vol. 7, 509-516
- https://doi.org/10.2147/ppa.s40736
Abstract
Medication possession ratio: implications of using fixed and variable observation periods in assessing adherence with disease-modifying drugs in patients with multiple sclerosis Chris M Kozma,1 Michael Dickson,2 Amy L Phillips,3 Dennis M Meletiche31CK Consulting Associates, LLC St Helena Island, SC, 2University of South Carolina College of Pharmacy, Columbia, SC, 3EMD Serono Inc, Rockland, MA, USABackground: The purpose of this study was to compare two methods of adherence calculation using administrative data for patients with multiple sclerosis (MS) who are prescribed disease-modifying drugs.Methods: Pharmacy-billed disease-modifying drug prescription claims were selected from the 2007–2008 LifeLink™ Health Plan Claims Database. The index date was the first disease-modifying drug prescription claim. Two cohorts were created: all patients with a disease-modifying drug claim in 2007 and a subset with continuous eligibility for 12 months post-index. Adherence was calculated across all disease-modifying drugs for 12 months post-index. Medication possession ratios (MPRs) with variable (start to end of therapy) and fixed (365 days) duration denominators were calculated. Variable MPR was calculated by summing days supply from the first to the last prescription (inclusive) divided by time between the last prescription date plus days supply and the first prescription date. Variable MPR was evaluated for all patients and the continuously eligible cohort. Fixed MPR used the same numerator but divided by 365 days of follow-up and evaluated only for the continuously eligible cohort.Results: There were 3405 patients with MS and a disease-modifying drug claim in 2007 and 2145 in the continuously eligible cohort. Means for variable MPR ranged from 87.5% ± 16.6% for the continuously eligible cohort to 90.5% ± 16.0% for the 2007 cohort. The comparable value for fixed MPR was 78.0% ± 28.2% for the continuously eligible cohort. Fixed MPR gave a consistently lower rate of adherence than variable MPR at an 80% adherence threshold.Conclusion: Different adherence measures can yield different outcomes, especially when using different eligibility criteria. These results demonstrate the importance of full disclosure of methods used for calculations and specification of the study population.Keywords: adherence, compliance, medication possession ratio, multiple sclerosis, disease-modifying drugKeywords
This publication has 12 references indexed in Scilit:
- Impact of medication adherence to disease-modifying drugs on severe relapse, and direct and indirect costs among employees with multiple sclerosis in the USJournal of Medical Economics, 2012
- Medication Compliance and Persistence: Terminology and DefinitionsValue in Health, 2008
- The impact of compliance with osteoporosis therapy on fracture rates in actual practiceOsteoporosis International, 2004
- Validation of Patient Reports, Automated Pharmacy Records, and Pill Counts With Electronic Monitoring of Adherence to Antihypertensive TherapyMedical Care, 1999
- Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practiceClinical Therapeutics, 1999
- Pill Count, Self-Report, and Pharmacy Claims Data to Measure Medication Adherence in the ElderlyAnnals of Pharmacotherapy, 1998
- The assessment of refill compliance using pharmacy records: Methods, validity, and applicationsJournal of Clinical Epidemiology, 1997
- Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and hypertension (AASK) pilot studyAmerican Journal of Hypertension, 1996
- Long-term patient compliance with prescribed regimens of calcium channel blockers.1994
- A General Method of Compliance Assessment Using Centralized Pharmacy RecordsMedical Care, 1988